Flemming Steen Jørgensen

Geciteerd door

	Alles	Sinds 2019
Citaties	3968	968
h-index	35	17
i10-index	77	32

220

110

165

19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202416 7 11 17 30 31 35 33 39 37 31 39 40 42 44 53 56 70 85 95 120 132 132 155 163 172 181 165 141 175 193 180 193 179 144 166 189 214 75

Openbare toegang

Alles bekijken

15 artikelen

2 artikelen

beschikbaar

niet beschikbaar

Op basis van financieringsmachtigingen

Medeauteurs

Lars OlsenDepartment of Drug Design and Pharmacology, University of CopenhagenGeverifieerd e-mailadres voor novozymes.com
Vasanthanathan PoongavanamUppsala UniversityGeverifieerd e-mailadres voor kemi.uu.se
Carsten Uhd NielsenDepartment of Physics, Chemistry and Pharmacy, Faculty of Sciences, University of Southern DenmarkGeverifieerd e-mailadres voor sdu.dk
Søren BrunakProfessor of Disease Systems Biology, University of CopenhagenGeverifieerd e-mailadres voor cpr.ku.dk
Birger BrodinProfessor, CNS drug delivery, University of CopenhagenGeverifieerd e-mailadres voor sund.ku.dk
Marco van de WeertAssociate Professor in Biologics formulation, University of CopenhagenGeverifieerd e-mailadres voor sund.ku.dk
Lars HemmingsenDepartment of Chemistry, University of CopenhagenGeverifieerd e-mailadres voor chem.ku.dk
Michael GajhedeProfessor i proteinkrystallografi, Københavns UniversitetGeverifieerd e-mailadres voor sund.ku.dk
R. Stan BrownProfessor of Chemistry, Queen's UniversityGeverifieerd e-mailadres voor chem.queensu.ca
Tudor OpreaCEO, Expert Systems IncGeverifieerd e-mailadres voor expertsystems.inc
Qiyuan LiSchool of Medicine, Xiamen UniversityGeverifieerd e-mailadres voor xmu.edu.cn
Anders Skov KristensenUniversity of CopenhagenGeverifieerd e-mailadres voor sund.ku.dk
Kasper B. HansenAssociate Professor, University of MontanaGeverifieerd e-mailadres voor mso.umt.edu
Henrik LeffersSenior Scientist, University of Copenhagen, Denmark. henrik@leffers.proGeverifieerd e-mailadres voor leffers.pro
Patrik RydbergAssociate Director, Computational Chemmistry, Optibrium Ltd.Geverifieerd e-mailadres voor optibrium.com
Jukka Rantanen, professor PhDUniversity of CopenhagenGeverifieerd e-mailadres voor sund.ku.dk
Hans Bräuner-OsborneProfessor of Molecular Pharmacology, University of CopenhagenGeverifieerd e-mailadres voor sund.ku.dk
Vignir IsbergSenior Department Manager, NovozymesGeverifieerd e-mailadres voor vignir.org
David N. CooperProfessor of Human Molecular Genetics, Cardiff University, UKGeverifieerd e-mailadres voor cardiff.ac.uk
Peter BrossResearch Unit for Molecular Medicine, Aarhus University HospitalGeverifieerd e-mailadres voor clin.au.dk

Volgen

Flemming Steen Jørgensen

Professor, Department of Drug Design and Pharmacology, University of Copenhagen

Geverifieerd e-mailadres voor sund.ku.dk

Molecular modelling computational chemistry structure-activity relationship


Titel Sorteren op citaties Sorteren op jaar Sorteren op titel	Geciteerd door Geciteerd door	Jaar
Study on the binding of Thioflavin T to β-sheet-rich and non-β-sheet cavities M Groenning, L Olsen, M van de Weert, JM Flink, S Frokjaer, ... Journal of structural biology 158 (3), 358-369, 2007	300	2007
GABAA receptor agonists, partial agonists, and antagonists. Design and therapeutic prospects P Krogsgaard-Larsen, B Frølund, FS Joergensen, A Schousboe Journal of medicinal chemistry 37 (16), 2489-2505, 1994	160	1994
Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates SÓ Jónsdóttir, FS Jørgensen, S Brunak Bioinformatics 21 (10), 2145-2160, 2005	146	2005
Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones C Kunick, K Lauenroth, K Wieking, X Xie, C Schultz, R Gussio, ... Journal of Medicinal Chemistry 47 (1), 22-36, 2004	138	2004
A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein− ligand binding affinities GE Terp, BN Johansen, IT Christensen, FS Jørgensen Journal of medicinal chemistry 44 (14), 2333-2343, 2001	138	2001
Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques P Vasanthanathan, O Taboureau, C Oostenbrink, NPE Vermeulen, ... Drug Metabolism and Disposition 37 (3), 658-664, 2009	117	2009
hERG classification model based on a combination of support vector machine method and GRIND descriptors Q Li, FS Jørgensen, T Oprea, S Brunak, O Taboureau Molecular pharmaceutics 5 (1), 117-127, 2008	113	2008
Prediction of cytochrome P450 mediated metabolism L Olsen, C Oostenbrink, FS Jørgensen Advanced drug delivery reviews 86, 61-71, 2015	111	2015
Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter J Andersen, L Olsen, KB Hansen, O Taboureau, FS Jørgensen, ... Journal of Biological Chemistry 285 (3), 2051-2063, 2010	108	2010
Structural differences of matrix metalloproteinases with potential implications for inhibitor selectivity examined by the GRID/CPCA approach GE Terp, G Cruciani, IT Christensen, FS Jørgensen Journal of medicinal chemistry 45 (13), 2675-2684, 2002	105	2002
Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia AM Buhl, J Jurlander, FS Jørgensen, AM Ottesen, JB Cowland, ... Blood 107 (7), 2904-2911, 2006	101	2006
Prediction of pH-dependent aqueous solubility of druglike molecules NT Hansen, I Kouskoumvekaki, FS Jørgensen, S Brunak, SO Jonsdottir Journal of chemical information and modeling 46 (6), 2601-2609, 2006	100	2006
Virtual screening and prediction of site of metabolism for cytochrome P450 1A2 ligands P Vasanthanathan, J Hritz, O Taboureau, L Olsen, F Steen Jørgensen, ... Journal of chemical information and modeling 49 (1), 43-52, 2009	88	2009
Recent advances in GABA agonists, antagonists and uptake inhibitors: structure–activity relationships and therapeutic potential P KROGSGAARD-LARSEN, H HJEDS, E FALCH, FS JØRGENSEN, ... Advances in drug research 17, 381-456, 1988	85	1988
SMARTCyp 3.0: enhanced cytochrome P450 site-of-metabolism prediction server L Olsen, M Montefiori, KP Tran, FS Jørgensen Bioinformatics 35 (17), 3174-3175, 2019	69	2019
New leads of metallo-β-lactamase inhibitors from structure-based pharmacophore design L Olsen, S Jost, HW Adolph, I Pettersson, L Hemmingsen, FS Jørgensen Bioorganic & medicinal chemistry 14 (8), 2627-2635, 2006	69	2006
Solvent diversity in polymorph screening M Allesø, F Van Den Berg, C Cornett, FS Jørgensen, B Halling-Sørensen, ... Journal of pharmaceutical sciences 97 (6), 2145-2159, 2008	68	2008
Primary structure and conformational analysis of peptide methionine—tyrosine, a peptide related to neuropeptide Y and peptide YY isolated from lamprey intestine JM CONLON, B Bjørnholm, FS Jørgensen, JH Youson, TW Schwartz European journal of biochemistry 199 (2), 293-298, 1991	62	1991
Cyclynes. Part 5. Pericyclynes:" exploded cycloalkanes" with unusual orbital interactions and conformational properties. MM2 and STO-3G calculations, x-ray crystal structures … KN Houk, LT Scott, NG Rondan, DC Spellmeyer, G Reinhardt, JL Hyun, ... Journal of the American Chemical Society 107 (23), 6556-6562, 1985	62	1985
Homology modelling of the GABA transporter and analysis of tiagabine binding S Skovstrup, O Taboureau, H Bräuner‐Osborne, FS Jørgensen ChemMedChem 5 (7), 986-1000, 2010	61	2010

Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.

Artikelen 1–20

Citaties per jaar

Dubbele citaties

Samengevoegde citaties

Medeauteurs toevoegenMedeauteurs

Volgen

Geciteerd door

Medeauteurs